Stokes Family Office’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,404
| Closed | -$254K | – | 259 |
|
|
2024
Q4 | $254K | Buy |
2,404
+6
| +0.3% | +$634 | 0.03% | 207 |
|
|
2024
Q3 | $259K | Buy |
2,398
+4
| +0.2% | +$432 | 0.03% | 198 |
|
|
2024
Q2 | $260K | Buy |
2,394
+5
| +0.2% | +$543 | 0.03% | 195 |
|
|
2024
Q1 | $315K | Buy |
2,389
+5
| +0.2% | +$660 | 0.04% | 183 |
|
|
2023
Q4 | $290K | Sell |
2,384
-114
| -5% | -$13.9K | 0.04% | 181 |
|
|
2023
Q3 | $280K | Buy |
2,498
+99
| +4% | +$11.1K | 0.03% | 255 |
|
|
2023
Q2 | $349K | Buy |
2,399
+8
| +0.3% | +$1.17K | 0.04% | 218 |
|
|
2023
Q1 | $309K | Buy |
2,391
+19
| +0.8% | +$2.46K | 0.04% | 218 |
|
|
2022
Q4 | $302K | Buy |
2,372
+7
| +0.3% | +$892 | 0.04% | 216 |
|
|
2022
Q3 | $247K | Sell |
2,365
-112
| -5% | -$11.7K | 0.04% | 229 |
|
|
2022
Q2 | $260K | Sell |
2,477
-10
| -0.4% | -$1.05K | 0.04% | 226 |
|
|
2022
Q1 | $318K | Sell |
2,487
-65
| -3% | -$8.31K | 0.04% | 202 |
|
|
2021
Q4 | $315K | Hold |
2,552
| – | – | 0.04% | 188 |
|
|
2021
Q3 | $363K | Buy |
2,552
+3
| +0.1% | +$427 | 0.05% | 168 |
|
|
2021
Q2 | $398K | Buy |
2,549
+3
| +0.1% | +$468 | 0.06% | 155 |
|
|
2021
Q1 | $396K | Buy |
2,546
+4
| +0.2% | +$622 | 0.06% | 148 |
|
|
2020
Q4 | $380K | Buy |
2,542
+16
| +0.6% | +$2.39K | 0.07% | 127 |
|
|
2020
Q3 | $334K | Buy |
2,526
+7
| +0.3% | +$926 | 0.08% | 120 |
|
|
2020
Q2 | $292K | Buy |
2,519
+2
| +0.1% | +$232 | 0.07% | 113 |
|
|
2020
Q1 | $247K | Buy |
2,517
+4
| +0.2% | +$393 | 0.07% | 109 |
|
|
2019
Q4 | $365K | Buy |
+2,513
| New | +$365K | 0.08% | 108 |
|